Mollugin: A Comprehensive Review of Its Multifaceted Pharmacological Properties and Therapeutic Potential
Sandra Ross Olakkengil Shajan, Bushra Zia, Charu Sharma, Sandeep B Subramanya, Shreesh Ojha, Ilian Badjakov, Ivayla Dincheva · 2025
Read Mollugin: A Comprehensive Review of Its Multifaceted Pharmacological Properties and Therapeutic Potential by Sandra Ross Olakkengil Shajan, Bushra Zia, Charu Sharma, Sandeep B Subramanya, Shreesh Ojha, Ilian Badjakov, Ivayla Dincheva (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732725.txt.
Description
Sandra Ross Olakkengil Shajan and co-authors review mollugin, a plant compound, in a 2025 survey of past lab work. The compound comes from the plant Rubia cardifolia and has drawn wide interest as a possible drug base. The review sums up what lab tests have shown about how it acts in cells and animals. It also covers man-made variants built to work better than the natural form.
Past tests link the compound to lower swelling, slower tumor growth, and guard effects for nerves and bone. It seems to act on many cell signals at once, which cuts both ways for drug design. Some variants show stronger effects and dissolve better in water. The authors say the breadth of action makes the compound a strong lead, but much work remains before any drug use.
Catalog record
| CREATOR | Sandra Ross Olakkengil Shajan, Bushra Zia, Charu Sharma, Sandeep B Subramanya, Shreesh Ojha, Ilian Badjakov, Ivayla Dincheva |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |